Virtual Reality and Computerized Cognitive Intervention for Mild Cognitive Impairment in Heart Failure
2 other identifiers
interventional
172
1 country
1
Brief Summary
This research project is relevant to public health because both heart failure (HF) and mild cognitive impairment (e.g., trouble remembering and concentrating beyond normal aging) are highly prevalent among older adults in the United States. Despite advances in health care, there are no effective interventions for treating cognitive impairment in HF, which if left untreated, leads to suboptimal health, quality of life, and shorter survival. Therefore, the investigators propose to test the effect of a dual-component intervention comprised of a virtual reality-based cognitive restoration intervention and computerized cognitive training on cognitive function and overall health among 172 older adults with HF who experience mild cognitive impairment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Apr 2023
Longer than P75 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 24, 2022
CompletedFirst Posted
Study publicly available on registry
November 1, 2022
CompletedStudy Start
First participant enrolled
April 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
March 23, 2026
March 1, 2026
4 years
October 24, 2022
March 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in cognitive function: attention
Trail Making and Number Span Test from National Alzheimer's Coordinating Center Neuropsychological battery (Uniform Data Set V3.0)
Baseline, 8 weeks, 16 weeks, and 1 year (52 weeks) after baseline
Changes in cognitive function: memory
Craft Story 21 and Benson Figure Copy for memory from National Alzheimer's Coordinating Center Neuropsychological battery (Uniform Data Set V3.0)
Baseline, 8 weeks, 16 weeks, and 1 year (52 weeks) after baseline
Secondary Outcomes (5)
Changes in heart failure self-care
Baseline, 8 weeks, 16 weeks, and 1 year (52 weeks) after baseline
Changes in instrumental activities of daily living
Baseline, 8 weeks, 16 weeks, and 1 year (52 weeks) after baseline
Changes in instrumental activities of daily living
Baseline, 8 weeks, 16 weeks, and 1 year (52 weeks) after baseline
Changes in health-related quality of life
Baseline, 8 weeks, 16 weeks, and 1 year (52 weeks) after baseline
Dementia-free survival
1 year after baseline
Study Arms (4)
Vita (virtual reality-based cognitive restoration intervention)
EXPERIMENTALParticipants randomized to Vita will receive a virtual reality head-mount device (e.g., Oculus Quest) to view nature pictures for 10 minutes (1 set of 10 pictures)/day, 2-3 days/week for 8 weeks (a total of 20 sets for 200 minutes, approximately 3.3 hours) based on the provided activity schedule. Participants will receive weekly check-in calls from the intervention RA during the 8 weeks of intervention phase.
Com (computerized cognitive training intervention )
EXPERIMENTALParticipants randomized to Com will receive a tablet computer (e.g., iPad) to complete BrainHQ training for 1 hour (6 exercises)/day, 2-3 days/week for 8 weeks (total of 20 hours) based on the provided activity schedule. Participants will receive weekly check-in calls from the intervention RA during the 8 weeks of intervention phase.
Vita+Com (Both Vita and Com intervention)
EXPERIMENTALParticipants randomized to Vita+Com will receive both Vita and Com simultaneously. They will spend 10 minutes on Vita and then 1 hour on Com per day, 2-3 days/week for 8 weeks (a total of 23.3 hours). Participants will receive weekly check-in calls from the intervention RA during the 8 weeks of intervention phase.
Usual care
NO INTERVENTIONParticipants randomized to this control condition will continue to receive their usual care, but no interventions from the study team. We will monitor changes in their activities that may affect changes in cognitive function (e.g., starting book clubs) by weekly check-in calls during the 8 weeks of intervention phase.
Interventions
Vita is developed by this study team based on Attention Restoration Theory. The Vita intervention involves viewing 360 degree nature pictures on a virtual reality headset.
Com intervention uses BrainHQ from PositScience that was developed based on the brain neuroplasticity. The com intervention involves doing game-like training on a iPad.
Vita+Com intervention is a combination of both Vita and Com interventions. Participants will be asked to complete Vita first and then Com intervention.
Eligibility Criteria
You may qualify if:
- ≥ 55 years;
- chronic HF Stage C validated from echocardiography or comparable measure or B-type natriuretic peptide (BNP) level \> 400 pg/ml \[or equivalent NT-proBNP\] in past 3 years;
- ability to communicate in English;
- capacity to consent according to the Indiana University Institutional Review Board policies, or lacks capacity to consent but has the ability to provide assent from someone who can serve as LAR; and
- Subjectively reported cognitive concern assessed by the question, "Do you have any trouble with your memory or thinking?".
You may not qualify if:
- pre-HF (Stages A and B) or advanced HF (Stage D);
- vision or hearing problems that can interfere with cognitive testing;
- major neurological disorder (e.g., previously diagnosed dementia, Parkinson's disease, epilepsy, multiple sclerosis);
- major psychiatric disease (e.g., schizophrenia, bipolar disorder);
- life-threatening unstable illness other than HF (e.g., end-stage cancer); and
- users of regular computerized cognitive training or participants in cognitive training trials in the past year.
- Second, we will enroll patients only if they have MCI or normal cognition by not meeting criteria for dementia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Indiana University
Indianapolis, Indiana, 46202, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Single-blind
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 24, 2022
First Posted
November 1, 2022
Study Start
April 3, 2023
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
March 31, 2027
Last Updated
March 23, 2026
Record last verified: 2026-03